A story in Thursday's issue of MDD about a study on opportunities in the peripheral vascular disease market issued by Scientia Advisors did not mean to imply that the study was a direct outgrowth of a project being done for one of the firm's clients. The company said the study grew out of its own interest in potential opportunities for companies in the PVD space.
To read more on related topics, click on one of the words below.